Optical Brightening Agent FU-D | CAS:27344-06-5

We serve Optical Brightening Agent FU-D CAS:27344-06-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Optical Brightening Agent FU-D

Optical Brightening Agent FU-D
 
Main composition
C.I.No:230
CAS No:27344-06-5
Molecular mass:1014.9961
Formula:C42H44N14Na2O10S2
Type of product:Mixture substance
 
Technical index  
Appearance:Amber transparent liquid
pH Value:8.0~11.0
Density:1.1~1.2g/cm3
Viscosity:≤250mpas
Ionic character:anion
 
Performance and Features  
1.Convenient in application, easily soluble, diluted with water.
2.It can be directly added into the pulp, but in the course of adding, should avoid adding together with the other cationic chemicals or directly contact, mix. Adding in the pulp, the proportion based on weight of between OBA and absolute dry paper pulp is 0.2％～5％.
3.During surface sizing, it has better performance with the carriers of CMC, PVA and starch. Usual dosage: 1~60g/L.
 
Packaging and Storage  
Packaging with 50kg or 230kg barrels, 1000kg IBC tank or special packages according to customers, store at the places with room temperature.



Contact us for information like Optical Brightening Agent FU-D chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Optical Brightening Agent FU-D physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Optical Brightening Agent FU-D Use and application,Optical Brightening Agent FU-D technical grade,usp/ep/jp grade.


Related News: In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.7-fluoroheptan-1-ol manufacturer In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.5-Fluoro-2-nitrobenzadehyde supplier “So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.5-fluorocytidine vendor “So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.In these situations, the API is not a single substance but the culmination of various ingredients.